Connect with us

Technology

Asia-Pacific private equity shows green shoots of recovery

Published

on

India and Japan have become hotspots for PE investorsDeal value increased, exits recovered, fund-raising remained challenging, dry powder declined

SINGAPORE, March 24, 2025 /PRNewswire/ — Despite another year of uncertain macroeconomic conditions, Asia-Pacific’s private equity (PE) market is showing signs of recovery after two years of decline as deal value rose 11% to $176 billion in 2024, according to Bain & Company’s Asia-Pacific Private Equity Report 2025 launched today. While the recovery is supported by moderate investments across the region, deal count declined 9% when compared with 2023.

Overall, Asia-Pacific deals were larger. Average deal size in the region rose to $133 million, up 22% over 2023 and 12% higher than the previous five-year (2019-2023) average. The number of megadeals, or deals valued at $1 billion or more, increased by 50% compared to 2023, lifting average deal size.

Buyouts continued to be in favor as they accounted for over half of 2024’s total deal value. Notably, the share of buyout deals rose in traditionally growth deal markets, including India, Southeast Asia, and Greater China. Lower interest rates across most of the region also fueled more buyouts.

In 2024, carve-out deals totaled 19% of all buyouts over $100 million. Despite lower average returns, 44% of Asia-Pacific general partners (GPs) surveyed by Bain consider carve-outs a top investment opportunity, possibly due to immense opportunities in Japan and Korea when conglomerates rationalize operations and sell off business units.

“Investors are still wary of market uncertainty and so we continue to see them favoring buyouts as a way for greater control to manage risks and ensure a clear path to increase value. For those looking at carve-outs, it is essential to have an actionable value creation plan,” said Sebastien Lamy, co-head of Bain & Company’s Asia-Pacific PE practice.

“And while most markets in Asia-Pacific saw deal value rising in 2024, the actual dealmaking activity varied widely across the region. India and Japan are looking to be hotspots as their active investor pools have risen and major global PE funds are planning to deploy more capital in these markets.”

Greater China continued to lead with the highest deal value in the region, but deal value only rose modestly compared to 2023, and its share of the market continued to drop accounting for 27% of the region’s total deal value in 2024. India was Asia-Pacific’s top performer, with deal value and count rising. The market remains one of the fastest growing in the region based on GDP, and investors are drawn to its strong growth fundamentals. Australia–New Zealand’s deal value more than doubled, fueled by the $16 billion AirTrunk deal. Japan’s deal count was unchanged, but deal value was down sharply vs. the previous year, which included multiple megadeals. In South Korea and Southeast Asia, dealmaking revived, with gains in deal value.

Some of the largest global fund managers with over two decades of investment experience in Asia-Pacific PE are shifting their focus away from China. Last year, these GPs closed almost twice as many deals in Japan and India compared to the average from 2014 to 2018. Their investments in Greater China, by contrast, declined to less than one-third of the same period. Looking forward, major global PE funds plan to deploy more capital in India and Japan.

Similarly, limited partners (LPs) recognize the attractiveness of India and Japan and endorse the strategic shift to those markets. In Preqin’s 2024 global LP survey, Japan ranked No. 4 globally for the best PE investment opportunities in developed markets (after the US, Western Europe, and the UK)—and among emerging markets, India ranked No. 1 globally.

Looking at industries, while technology continued to lead with the highest share of deal value and count across the region, its share of deal value shrank to 25% in 2024, down from 50% in 2018, as GPs sought greater diversity in their portfolios in an uncertain environment. Investments in communications and financial services showed the highest growth rates in deal value over the previous year, powered by several large deals in data centers, and sizable deals in property loan and personal loan businesses in India.

The challenging private equity environment in Asia-Pacific is squeezing out bottom-ranked investors. In 2024, the number of active investors declined 10%—the second drop in two years. In contrast, the top 20 investors’ share of total deal value remained high at 41%. Japan and India are proving to be attractive markets for PE investors as the number of active investors in Japan rose 14% in 2024, bucking a regional trend of shrinking competition, while in India, active investors rose 29%, helping fuel an increase in deal count and deal value. Global investment firms are also setting up offices in these two markets.

Deal multiples—the ratio of enterprise value to EBIDTA—edged up to 12.8 from 10.3 a year earlier due to rising valuations of comparable companies listed on public markets across the region and public market recoveries or rallies.

Most markets saw some improvement in exit value and count in 2024, with India being the region’s largest exit market in terms of value and count, supported by a vibrant IPO market. Due to a sharp decline in China’s exit market – partly driven by Greater China’s weak stock market performance – total exit value and count for the region were roughly flat, ending two years of precipitous decline.

For the third consecutive year, investors raising new funds (excluding RMB funds) continued to face significant challenges. The value of Asia-Pacific-focused funds raised in 2024 slumped to a 10-year low of $74 billion, down more than 20% year on year, and 43% lower than the previous five-year average. Global fund-raising in 2024 was down 23%, excluding RMB funds, and Asia-Pacific’s share of global fund-raising was a low 7%, down from 13% in 2021.

Dry powder, or total unspent PE capital, declined for the Asia-Pacific region from its record level in 2023. A challenging fund-raising environment contributed to the dip.

“Green shoots are appearing in Asia-Pacific’s PE market and despite ongoing challenges and a still uncertain macro environment, fund managers are more optimistic about 2025,” said Prabhav Addepalli, a Bain & Company PE partner, based in New Delhi. “The region’s fund managers have mixed expectations on future returns, but our survey highlighted a noticeable optimism, with 87% of respondents stating they believe returns will not decrease in the coming three to five years, up from 61% in 2023.”

Media contact:
Ann Leeann.lee@bain.com

About Bain & Company

Bain & Company is a global consultancy that helps the world’s most ambitious change makers define the future.

Across 65 cities in 40 countries, we work alongside our clients as one team with a shared ambition to achieve extraordinary results, outperform the competition, and redefine industries. We complement our tailored, integrated expertise with a vibrant ecosystem of digital innovators to deliver better, faster, and more enduring outcomes. Our 10-year commitment to invest more than $1 billion in pro bono services brings our talent, expertise, and insight to organizations tackling today’s urgent challenges in education, racial equity, social justice, economic development, and the environment. We earned a platinum rating from EcoVadis, the leading platform for environmental, social, and ethical performance ratings for global supply chains, putting us in the top 1% of all companies. Since our founding in 1973, we have measured our success by the success of our clients, and we proudly maintain the highest level of client advocacy in the industry.

View original content to download multimedia:https://www.prnewswire.com/news-releases/asia-pacific-private-equity-shows-green-shoots-of-recovery-302409146.html

SOURCE Bain & Company

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Afficient Academy Launches AI-Driven SAT Preparation Suite

Published

on

By

Maximize SAT Success with Personalized, Adaptive Learning.

SAN JOSE, Calif., March 28, 2025 /PRNewswire-PRWeb/ — Afficient Academy, a leader in AI-driven education solutions, proudly announces the launch of its groundbreaking SAT Preparation Suite, empowering students to efficiently maximize their SAT scores, and transforming SAT preparation from overwhelming to overachieving!

Afficient’s AI-Driven SAT Preparation Suite helps achieve high scores efficiently.

Building on the success of its AI-driven K-12 programs Afficient Math and Afficient English, which have been proven to help students learn 2-5 times faster than traditional methods while achieving superior results, Afficient Academy now brings its advanced technology to SAT preparation.

With its data-driven, AI-powered approach, Afficient Academy’s SAT Preparation suite leverages:

Over 3,000 comprehensive and rigorous exercises to build essential skills

Targeted and personalized learning paths to accelerate learning

Eight full-length digital SAT practice tests and customized post-test practice to enhance test-taking confidence and performance.

AI-Powered Comprehensive SAT Mastery

Afficient Academy’s SAT Preparation suite includes three meticulously designed products:

Afficient SAT Math – Covers Algebra, Problem Solving and Data Analysis, Advanced Math, Geometry & Trigonometry, ensuring thorough understanding of mathematical concepts and mastering of problem-solving skills.Afficient SAT Reading & Writing – Enhances skills in Craft and Structure, Information and Ideas, Standard English Conventions, and Expression of Ideas, building strong reading comprehension and writing proficiency.Afficient SAT/ACT Vocabulary – Features 1,500 primary words and 2,000+ additional words, efficiently enhancing vocabulary knowledge and retention through adaptive exercises in word recognition and application.

Key Features and Benefits

Comprehensive Content Coverage – Master all SAT areas, including Vocabulary, Reading, Writing and Math, with in-depth instruction, helpful test-taking strategies, and extensive practice exercises.

AI-Powered Personalization – Predicts performance, customizes exercises, and tailors learning strategies to help students achieve their target SAT scores.

Proven Learning Acceleration – Afficient Academy’s patented technology delivers a result-oriented, optimized learning path to close learning gaps and efficiently achieve learning goals.

Full-Length Digital Practice Tests – Comprehensive digital practice exams assess student readiness, followed by customized post-test practice.

Flexible Learning Options – Offers both self-paced learning and instructor-led courses, catering to diverse student needs.

Expert-Designed Curriculum – Created by experienced education and technology professionals with a proven track record in delivering successful K-12 math and English learning solutions.

“We are thrilled to introduce an innovative SAT preparation platform that personalizes and accelerates student learning,” said Dr. Jiayuan Fang, President and CEO of Afficient Academy. “Our mission is to empower students with cutting-edge technology that enables them to reach their full academic potential.”

Availability

Afficient Academy’s AI-driven SAT Preparation Products are now available and can be accessed at:

https://www.afficienta.com/sat-test-preparation/

About Afficient Academy, Inc.

Founded in 2014 in Silicon Valley Californai, Afficient Academy is a pioneer in AI-powered learning solutions for math and English education. With patented, WASC-accredited programs used by thousands of students in 20+ countries, Afficient Academy delivers efficient, accelerated learning experiences that drive academic success.

Press Contact

Dilip Acharya

VP of Business Development and Marketing

dilip.acharya@afficienta.com

408-382-9458

Media Contact

Dilip Acharya, Afficient Academy, Inc., 1 4086277590, dilip.acharya@afficienta.com, https://afficienta.com 

View original content to download multimedia:https://www.prweb.com/releases/afficient-academy-launches-ai-driven-sat-preparation-suite-302413995.html

SOURCE Afficient Academy, Inc.

Continue Reading

Technology

WELL Health Announces Delay in Filing of Annual Audited Financial Statements Due to Matter Related to US Subsidiary Circle Medical

Published

on

By

VANCOUVER, BC, March 28, 2025 /PRNewswire/ – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“WELL” or the “Company”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces that it will be delaying the filing of its audited annual consolidated financial statements for the year ended December 31, 2024, the related management’s discussion and analysis, and related CEO and CFO certificates (collectively, the “Required Filings”) beyond the March 31, 2025 deadline (the “Deadline”).

The delay is resulting from the accounting implications related to the Company’s non-wholly owned Delaware subsidiary Circle Medical Technologies, Inc. (“Circle Medical”), as described in further detail below. In fiscal 2023, Circle Medical contributed a net loss of $1.1 million to WELL’s consolidated net income of $16.6 million and contributed less than 2.7% to WELL’s consolidated Adjusted EBITDA(1).

In September 2024, Circle Medical received a request for the voluntary production of documents and information (“RFI”) from the Civil Division of the United States Attorney’s Office for the Northern District of California (“USAO”) investigating certain of Circle Medical’s billing practices in the US. Circle Medical has been responding to the RFI and engaging with the USAO to address and resolve this matter.  Additional information and analysis regarding the impact of the USAO RFI is necessary in order to finalise Circle Medical’s financial statements and by extension, the Company’s annual consolidated financial statements for the year ended December 31, 2024. The production of information by Circle Medical and analysis by the Company for the financial statements is not expected to be completed prior to the March 31, 2025 filing deadline for the Required Filings.

The Company does not expect the resolution of the matter to have a material effect on the Company’s cash position or available resources. The Company and Circle Medical are currently working diligently to finalise the Company’s annual consolidated financial statements at the earliest possible date. The Company currently expects to be in a position to file the Required Filings on or before April 15, 2025 (the “Filing Interval”).

Notwithstanding the foregoing, the Company confirms that it continues to seek strategic alternatives for Circle Medical and is committed to carrying out this process in due course.

The Company has applied to the British Columbia Securities Commission, as principal regulator for the Company, for the imposition of a management cease trade order under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”) throughout the duration of the Filing Interval. However, there can be no assurance that a management cease trade order will be granted. The management cease trade order, if approved, will not affect the ability of persons who are not or have not been management of the Company to trade in its securities.

WELL confirms that it will satisfy the provisions of the alternative information guidelines under NP 12-203 by issuing bi-weekly default status reports, if necessary, in the form of news releases for so long as it remains in default of the above-noted filing requirements. The British Columbia Securities Commission may issue a general cease trade order against WELL for failure to file the Required Filings within the prescribed time period or sooner if WELL fails to file the prescribed status reports.

Other than as disclosed herein, WELL is up to date in its filing obligations.

Footnote:

1.

Non-GAAP Financial Measures – Adjusted EBITDA

In addition to results reported in accordance with IFRS, the Company uses Adjusted EBITDA as a supplemental indicator of its financial and operating performance. The Company believes this non-GAAP financial measure reflects the Company’s ongoing business in a manner that allows for meaningful period-to-period comparisons and analysis of trends in its business. The Company defines Adjusted EBITDA as net income (loss) before interest, taxes, depreciation and amortization less (i) net rent expense on premise leases considered to be finance leases under IFRS and before (ii) transaction, restructuring, and integration costs, time-based earn-out expense, change in fair value of investments, share of income (loss) of associates, foreign exchange gain/loss, and stock-based compensation expense, and (iii) gains/losses that are not reflective of ongoing operating performance. The Company considers Adjusted EBITDA to be a financial metric that measures cash flow that can be used to fund working capital requirements, service future interest and principal debt repayments, and fund future growth initiatives. Adjusted EBITDA should not be considered an alternative to net income (loss), cash flow from operating activities, or other measures of financial performance defined under IFRS. A reconciliation of Adjusted EBITDA to the most directly comparable IFRS measure can be found in the Company’s Fiscal 2023 Annual MD&A.

WELL HEALTH TECHNOLOGIES CORP.

Per: “Hamed Shahbazi”

Hamed Shahbazi

Chief Executive Officer, Chairman and Director 

About WELL Health Technologies Corp.

WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 41,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about the Company, please visit: www.well.company.

Forward-Looking Information

This news release contains “Forward-Looking Information” within the meaning of applicable Canadian securities laws, including, without limitation: statements regarding the grant of a management cease trade order, expected timing of the Required Filings, the impact of the resolution of the USAO RFI on WELL, and the ability to consummate strategic alternatives for Circle Medical. Forward-Looking Information is based on a number of estimates and assumptions are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond WELL’s control, which could cause actual results and events to differ materially from those disclosed in this news release. Forward-Looking Information generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe”, “goal” or “continue”, or the negative thereof or similar variations. Forward-Looking Information involves known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information is not a guarantee of future results or performance. WELL’s comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL’s control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including the risk factors identified in documents filed by WELL under its profile at www.sedar.com, including its most recent Annual Information Form and its most recent Management’s Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.

View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-announces-delay-in-filing-of-annual-audited-financial-statements-due-to-matter-related-to-us-subsidiary-circle-medical-302414821.html

SOURCE WELL Health Technologies Corp.

Continue Reading

Technology

Engineering Design & Testing Corp. Welcomes Paul Saedler as Consulting Engineer

Published

on

By

Engineering Design & Testing Corp. (EDT) has welcomed Paul Saedler, P.E., ACTAR, as a Consulting Engineer based in Los Angeles. With nearly 35 years of experience in mechanical engineering and accident reconstruction, Saedler enhances EDT’s capabilities in complex forensic investigations involving vehicles and mechanical systems.

LOS ANGELES, March 28, 2025 /PRNewswire-PRWeb/ — Engineering Design & Testing Corp. (EDT), a leading provider of forensic engineering and consulting services, has announced the addition of Paul Saedler, P.E., ACTAR, as a Consulting Engineer. Saedler brings nearly 35 years of experience in mechanical engineering and accident reconstruction to EDT’s growing national team.

“I’ve spent my career understanding why mechanical systems fail and helping clients make sense of it. At EDT, I get to work with top engineers at a firm that values objectivity, thoroughness, and real-world problem solving.” — Paul Saedler

Based in the Los Angeles area, Saedler specializes in forensic investigations involving passenger vehicles, commercial trucks, trailers, and motorcycles, with expertise in mechanical failure analysis and event data recorder (EDR) downloads. He is a registered professional engineer in California, Washington, Nevada, Arizona, and Hawaii, and holds certification from the Accreditation Commission for Traffic Accident Reconstruction (ACTAR #1914).

“We’re excited to welcome Paul to EDT,” said Taylor Russell, District Engineering Manager at EDT. “His combination of technical knowledge and decades of hands-on industry experience strengthens our ability to support clients with objective analysis in even the most complex incidents.”

Before joining EDT, Saedler held senior engineering roles at Rimkus Consulting Group, Daimler Chrysler, Fleetwood Enterprises, and Wahlco Inc., where he led investigations into mechanical systems, product failures, and large-scale vehicle incidents.

“I’ve dedicated my career to understanding how and why mechanical systems fail—and helping clients make sense of what happened,” said Saedler. “Joining EDT gives me the opportunity to collaborate with top-tier engineers and contribute to a firm that prioritizes objectivity, thoroughness, and real-world problem solving.”

Saedler is available immediately to consult on vehicle accident reconstruction and mechanical failure investigations for insurance carriers, law firms, and corporations across the region.

Media Contact

Pilar Lewis, Engineering Design & Testing Corp. (EDT), 1 4044019755, plewis@marketri.com, https://www.edtengineers.com/ 

View original content to download multimedia:https://www.prweb.com/releases/engineering-design–testing-corp-welcomes-paul-saedler-as-consulting-engineer-302413134.html

SOURCE Engineering Design & Testing Corp. (EDT)

Continue Reading

Trending